MAST Biosurgery AG
MAST Biosurgery AG is a privately held biosurgery company founded in 2004, operating through its San Diego-based US subsidiary MAST Biosurgery USA, Inc., with 11-50 employees focused on the surgical biomaterials sector.
- Company typePrivate
- Founded2004
- HeadquartersSan Diego, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What MAST Biosurgery AG does
MAST Biosurgery AG is a privately held biosurgery company founded in 2004, with operational presence in the United States through its wholly owned subsidiary MAST Biosurgery USA, Inc., headquartered in San Diego, California. The 'AG' designation and the dual subsidiary structure indicate a Swiss-domiciled parent with US commercial operations, a common organizational form for European medical device firms entering the US market. The company's name and sector positioning place it in the surgical biomaterials / biosurgery space, which typically encompasses products such as hemostats, sealants, tissue adhesives, anti-adhesion barriers, and bone graft substitutes used in surgical procedures. With a workforce of 11-50 employees, MAST Biosurgery is positioned as a small, specialty player in this market segment.
The firm is privately held with no public ticker, no disclosed funding rounds, and no investor information available in the source material. Its operating footprint, based on the US subsidiary structure, appears concentrated in the United States, though the Swiss parent structure may indicate broader international activity. No specific product lines, pricing models, distribution channels, customer segments, partnerships, leadership team details, or revenue figures were accessible in the provided source data, which consisted primarily of a website verification/waiting page (mastbio.com) returning no substantive company content. Investment-relevant signals — including pipeline, regulatory clearances, sales channels, and capital structure — are absent from the input, limiting any deeper analytical assessment.
Given the data gaps, the company's current status (whether actively commercializing products, in R&D, or in a different lifecycle phase) cannot be definitively established from the supplied evidence alone.
MAST Biosurgery AG firmographics
Firmographics- Name
- MAST Biosurgery AG
- Legal name
- MAST Biosurgery AG
- Website
- https://mastbio.com
- Company type
- Private
- Founded year
- 2004
- Headcount range
- 11–50 employees
- Short description
- MAST Biosurgery AG is a privately held biosurgery company founded in 2004, operating through its San Diego-based US subsidiary MAST Biosurgery USA, Inc., with 11-50 employees focused on the surgical biomaterials sector.
- Ownership category
- akta.pro rank
MAST Biosurgery AG industry classification
Industry- Product category
- Biosurgery / Surgical Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Biodegradable Medical & Hygiene Materials (absorbables, disposables substrates) (IMAEAOAL)
- akta.pro secondary industry
- Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends) (IMANAAAG)
Keywords
Where MAST Biosurgery AG is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
MAST Biosurgery AG business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales
MAST Biosurgery AG product offering
Product offeringCore offering
MAST Biosurgery AG is a privately held biosurgery company that develops and supplies medical products used in surgical procedures. Operating through its wholly owned US subsidiary, MAST Biosurgery USA, Inc. (San Diego, California), the company focuses on surgical adjunct products for the operating room. Specific product details, SKU-level descriptions, and indications are not available in the provided source data because the company website content was only a verification/placeholder page.
Product overview
Based on the available source data, no specific product or service information was accessible. The source content consisted only of a website verification placeholder page ("One moment, please...") rather than substantive company content.
Differentiator
Problem solved
Functional benefit
Companies that use MAST Biosurgery AG
Customer profileIdeal customer profiles1 record
MAST Biosurgery AG technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MAST Biosurgery AG competitors and assessment
Company assessmentDirect peers
- LifeNet Health: LifeNet Health is a regenerative medicine company offering biologic and bio-implant products for soft-tissue and hernia repair, directly comparable to MAST's biodegradable/bioresorbable surgical portfolio.
- Integra LifeSciences: Integra LifeSciences manufactures regenerative and bioresorbable surgical products, including tissue reinforcement meshes and wound matrices, directly overlapping with MAST's biosurgery positioning.
- Novus Scientific: Novus Scientific develops and commercializes resorbable synthetic surgical meshes (e.g., TIGR Matrix) for soft-tissue reinforcement, making it a close direct peer to MAST's bioresorbable mesh focus.
- W. L. Gore & Associates (Gore Medical): Gore Medical is a leading producer of surgical meshes and soft-tissue reinforcement products, including bioabsorbable and hybrid meshes. It competes head-to-head with MAST in hernia and abdominal wall repair.
Broad incumbents
- Cook Medical: Cook Medical supplies a broad range of surgical implants and bioabsorbable devices, including soft-tissue repair products sold through hospital channels overlapping MAST's go-to-market.
- Becton, Dickinson and Company (BD): BD's surgical and biosurgery portfolio (including the former C.R. Bard hernia mesh lines) directly overlaps with MAST's soft-tissue repair focus and represents the same customer base of general surgeons and hospitals.
- Ethicon (Johnson & Johnson): Ethicon is the dominant surgical mesh and biosurgery franchise within J&J, offering a broad portfolio of resorbable and permanent surgical products. It is the most relevant benchmark for MAST's bioresorbable surgical materials business.
- Baxter International: Baxter's surgical solutions business includes biosurgical products such as hemostats, sealants, and tissue matrices, serving overlapping surgical specialties and hospitals as MAST.
Others
- Tepha Inc. Tepha develops P4HB bioresorbable polymers used as raw material in resorbable surgical meshes and other implants. As a materials/enabling technology provider in the same resorbable value chain as MAST, it is thematically comparable.
Emerging players
- TELA Bio: TELA Bio is a smaller, growth-stage surgical mesh company focused on soft-tissue reconstruction with biologic and resorbable products — a closely comparable business model and product focus to MAST.
Market position
Strengths3 records
Weaknesses3 records
Key risks3 records
Key highlights3 records
Customer concentration
MAST Biosurgery AG social profiles
Digital presenceMAST Biosurgery AG financial estimates
Financial estimateRevenue estimate
Valuation estimate
MAST Biosurgery AG leadership team
Management profileNumber of profiles
MAST Biosurgery AG funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MAST Biosurgery AG M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MAST Biosurgery AG
What does MAST Biosurgery AG do?
MAST Biosurgery AG is a privately held biosurgery company that develops and supplies medical products used in surgical procedures. Operating through its wholly owned US subsidiary, MAST Biosurgery USA, Inc. (San Diego, California), the company focuses on surgical adjunct products for the operating room. Specific product details, SKU-level descriptions, and indications are not available in the provided source data because the company website content was only a verification/placeholder page.
When was MAST Biosurgery AG founded?
MAST Biosurgery AG was founded in 2004. It employs 11 to 50 people.
Where is MAST Biosurgery AG based?
MAST Biosurgery AG is headquartered in San Diego, United States, in the North America region.
Who are MAST Biosurgery AG's main competitors?
Direct peers on record are LifeNet Health, Integra LifeSciences, Novus Scientific and W. L. Gore & Associates (Gore Medical). Broad incumbents are Cook Medical, Becton, Dickinson and Company (BD), Ethicon (Johnson & Johnson) and Baxter International. Tepha Inc. is listed as an others. TELA Bio is listed as an emerging player.
Does MAST Biosurgery AG have an API?
No public API is recorded for MAST Biosurgery AG.
What industry is MAST Biosurgery AG in?
MAST Biosurgery AG's product category is Biosurgery / Surgical Medical Devices. Its primary akta.pro industry code is IMAEAOAL, Biodegradable Medical & Hygiene Materials (absorbables, disposables substrates), with a secondary code of IMANAAAG, Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends). Its NAICS code is 339113 and its SIC code is 3841.